EVERTEC (EVTC) Competitors

HealthEquity (NASDAQ:HQY) and EVERTEC (NYSE:EVTC) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, community ranking, valuation, earnings, dividends, analyst recommendations and risk.

Which has more risk and volatility, HQY or EVTC?

HealthEquity has a beta of 0.52, meaning that its share price is 48% less volatile than the S&P 500. Comparatively, EVERTEC has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500.

Do analysts rate HQY or EVTC?

HealthEquity presently has a consensus target price of $107.23, indicating a potential upside of 4.15%. EVERTEC has a consensus target price of $35.00, indicating a potential upside of 0.46%. Given HealthEquity's stronger consensus rating and higher possible upside, research analysts clearly believe HealthEquity is more favorable than EVERTEC.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	0 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.92
EVERTEC	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Do insiders and institutionals have more ownership in HQY or EVTC?

99.6% of HealthEquity shares are held by institutional investors. Comparatively, 96.8% of EVERTEC shares are held by institutional investors. 2.2% of HealthEquity shares are held by insiders. Comparatively, 0.8% of EVERTEC shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Does the media prefer HQY or EVTC?

In the previous week, HealthEquity had 19 more articles in the media than EVERTEC. MarketBeat recorded 23 mentions for HealthEquity and 4 mentions for EVERTEC. EVERTEC's average media sentiment score of 1.38 beat HealthEquity's score of 0.89 indicating that EVERTEC is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	13 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
EVERTEC	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is HQY or EVTC more profitable?

EVERTEC has a net margin of 10.20% compared to HealthEquity's net margin of 9.61%. EVERTEC's return on equity of 33.01% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	9.61%	9.01%	5.73%
EVERTEC	10.20%	33.01%	8.85%

Does the MarketBeat Community favor HQY or EVTC?

HealthEquity received 246 more outperform votes than EVERTEC when rated by MarketBeat users. Likewise, 69.88% of users gave HealthEquity an outperform vote while only 59.21% of users gave EVERTEC an outperform vote.

Company	Underperform	Outperform
HealthEquity	Outperform Votes 529 69.88%	Underperform Votes 228 30.12%
EVERTEC	Outperform Votes 283 59.21%	Underperform Votes 195 40.79%

Which has stronger earnings & valuation, HQY or EVTC?

EVERTEC has lower revenue, but higher earnings than HealthEquity. EVERTEC is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$999.59M	8.99	$55.71M	$1.20	85.80
EVERTEC	$694.71M	3.19	$79.72M	$1.28	27.22

Summary

HealthEquity beats EVERTEC on 11 of the 18 factors compared between the two stocks.